Skip to main content
NCBI home page
Gut logoLink to Gut
. 1969 Sep;10(9):717–722. doi: 10.1136/gut.10.9.717

Effect of cholestyramine on the absorption of vitamin D3 and calcium

W Grant Thompson, Gilbert R Thompson
PMCID: PMC1552980  PMID: 4318526

Abstract

The absorption of 10 μg doses of vitamin D3-3H in rats was found to be decreased by the addition of cholestyramine to the diet in an amount sufficient to cause steatorrhoea. Studies in vitro suggested that the effect of cholestyramine was due to its known ability to bind bile salts and thus disrupt micelles containing vitamin D.

The absorption of 1 mg 47calcium chloride was similar in both control and cholestyramine-fed rats, whether estimated by the whole body counting or the faecal excretion technique.

These findings show that the administration of cholestyramine causes a reduction in the absorption of vitamin D3-3H but not of radiocalcium.

Full text

PDF
717

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avioli L. V., Lee S. W., McDonald J. E., Lund J., DeLuca H. F. Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest. 1967 Jun;46(6):983–992. doi: 10.1172/JCI105605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRISCOE A. M., RAGAN C. ENHANCEMENT OF CALCIUM ABSORPTION IN MAN BY A BILE ACID SEQUESTRANT. Am J Clin Nutr. 1963 Nov;13:277–284. doi: 10.1093/ajcn/13.5.277. [DOI] [PubMed] [Google Scholar]
  3. CAREY J. B., Jr, WILLIAMS G. Relief of the pruritus of jaundice with a bile-acid sequestering resin. JAMA. 1961 May 6;176:432–435. doi: 10.1001/jama.1961.03040180034008. [DOI] [PubMed] [Google Scholar]
  4. CARLSSON A., LINDQUIST B. Comparison of intestinal and skeletal effects of vitamin D in relation to dosage. Acta Physiol Scand. 1955 Dec 22;35(1):53–55. doi: 10.1111/j.1748-1716.1955.tb01263.x. [DOI] [PubMed] [Google Scholar]
  5. DATTA D. V., SHERLOCK S. Treatment of pruritus of obstructive jaundice with cholestyramine. Br Med J. 1963 Jan 26;1(5325):216–219. doi: 10.1136/bmj.1.5325.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  7. Gallo D. G., Bailey K. R., Sheffner A. L. The interaction between cholestyramine and drugs. Proc Soc Exp Biol Med. 1965 Oct;120(1):60–65. doi: 10.3181/00379727-120-30443. [DOI] [PubMed] [Google Scholar]
  8. HASHIM S. A., BERGEN S. S., Jr, VAN ITALLIE T. B. Experimental steatorrhea induced in man by bile acid sequestrant. Proc Soc Exp Biol Med. 1961 Jan;106:173–175. doi: 10.3181/00379727-106-26275. [DOI] [PubMed] [Google Scholar]
  9. HOFMANN A. F. The behavior and solubility of monoglycerides in dilute, micellar bile-salt solution. Biochim Biophys Acta. 1963 Jun 18;70:306–316. doi: 10.1016/0006-3002(63)90754-6. [DOI] [PubMed] [Google Scholar]
  10. Harkins R. W., Hagerman L. M., Sarett H. P. Absorption of dietary fats by the rat in cholestyramine-induced steatorrhea. J Nutr. 1965 Sep;87(1):85–92. doi: 10.1093/jn/87.1.85. [DOI] [PubMed] [Google Scholar]
  11. Hertoghe J. J., Phinney S. B., Rubini M. E. Intestinal absorption and body retention of 47Ca in rats: evaluation of the method. J Nutr. 1967 Dec;93(4):454–460. doi: 10.1093/jn/93.4.454. [DOI] [PubMed] [Google Scholar]
  12. Howard R. P., Brusco O. J., Furman R. H. Effect of cholestyramine administration on serum lipids and on nitrogen balance in familial hypercholesterolemia. J Lab Clin Med. 1966 Jul;68(1):12–20. [PubMed] [Google Scholar]
  13. LENGEMANN F. W., DOBBINS J. W. The role of bile in calcium absorption. J Nutr. 1958 Sep 10;66(1):45–54. doi: 10.1093/jn/66.1.45. [DOI] [PubMed] [Google Scholar]
  14. SCHACHTER D., FINKELSTEIN J. D., KOWARSKI S. METABOLISM OF VITAMIN D. I. PREPARATION OF RADIOACTIVE VITAMIN D AND ITS INTESTINAL ABSORPTION IN THE RAT. J Clin Invest. 1964 May;43:787–796. doi: 10.1172/JCI104965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SCHAFFNER F., KLION F. M., LATUFF A. J. THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS. Gastroenterology. 1965 Mar;48:293–298. [PubMed] [Google Scholar]
  16. TENNENT D. M., SIEGEL H., ZANETTI M. E., KURON G. W., OTT W. H., WOLF F. J. Plasma cholesterol lowering action of bile acid binding polymers in experimental animals. J Lipid Res. 1960 Oct;1:469–473. [PubMed] [Google Scholar]
  17. Thompson G. R., Lewis B., Booth C. C. Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest. 1966 Jan;45(1):94–102. doi: 10.1172/JCI105327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. VISINTINE R. E., MICHAELS G. D., FUKAYAMA G., CONKLIN J., KINSELL L. W. Xanthomatous biliary cirrhosis treated with cholestyramine. A bile-acid-adsorbing resin. Lancet. 1961 Aug 12;2(7198):341–343. doi: 10.1016/s0140-6736(61)90634-1. [DOI] [PubMed] [Google Scholar]
  19. WHITESIDE C. H., HARKINS R. W., FLUCKIGER H. B., SARETT H. P. UTILIZATION OF FAT-SOLUBLE VITAMINS BY RATS AND CHICKS FED CHOLESTYRAMINE, A BILE ACID SEQUESTRANT. Am J Clin Nutr. 1965 Mar;16:309–314. doi: 10.1093/ajcn/16.3.309. [DOI] [PubMed] [Google Scholar]
  20. Webling D. D., Holdsworth E. S. Bile salts and calcium absorption. Biochem J. 1966 Sep;100(3):652–660. doi: 10.1042/bj1000652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wells R. F., Knepshield J. H., Davis C. Right upper quadrant calcification in a patient receiving long-term cholestyramine therapy for primary biliary cirrhosis. Am J Dig Dis. 1968 Jan;13(1):86–94. doi: 10.1007/BF02239213. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES